Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Harvard Business School
Dow
Medtronic
Baxter

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Talinolol

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Talinolol: Patents, clinical trial progress, indications

Talinolol is an investigational drug.

There have been 4 clinical trials for Talinolol. The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2011.

The most common disease conditions in clinical trials are Obesity, Morbid and [disabled in preview]. The leading clinical trial sponsors are University Medicine Greifswald, Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH, and Matthias Schwab.

Recent Clinical Trials for Talinolol
TitleSponsorPhase
Open Label Study for the Functional Characterization of Drug Metabolism and TransportMatthias SchwabPhase 1
Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric WaterUniversity Medicine GreifswaldPhase 1
Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug PharmacokineticsInstitut fuer anwendungsorientierte Forschung und klinische Studien GmbHPhase 1

See all Talinolol clinical trials

Clinical Trial Summary for Talinolol

Top disease conditions for Talinolol
Top clinical trial sponsors for Talinolol

See all Talinolol clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Mallinckrodt
Colorcon
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.